Free shipping on all orders over $ 500

AC-4-130 

Cat. No. M28939
AC-4-130  Structure
Size Price Availability Quantity
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

AC-4-130 is a potent STAT5 SH2 domain inhibitor. AC-4-130 directly binds to STAT5 and disrupts STAT5 activation, dimerization, nuclear translocation, and STAT5-dependent gene transcription. AC-4-130 induces cell cycle arrest and apoptosis in FLT3-ITD-driven leukemic cells. AC-4-130 has anti-cancer activity and can efficiently block pathological levels of STAT5 activity in acute myeloid leukemia (AML).

Chemical Information
Molecular Weight 751.2
Formula C37H36ClF5N2O5S
CAS Number 1834571-82-2
Form Solid
Solubility (25°C) DMSO 100 mg/mL (ultrasonic)
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] I Garces de Los Fayos Alonso, et al. Mol Cancer. PDGFRβ promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma

[2] Katja Seipel, et al. Int J Mol Sci. Rationale for a Combination Therapy with the STAT5 Inhibitor AC-4-130 and the MCL1 Inhibitor S63845 in the Treatment of FLT3-Mutated or TET2-Mutated Acute Myeloid Leukemia

[3] Emir Hadzijusufovic, et al. Cancers (Basel). STAT5 is Expressed in CD34+/CD38- Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms

[4] Bettina Wingelhofer, et al. Leukemia. Pharmacologic inhibition of STAT5 in acute myeloid leukemia

Related STAT Products
STAT3-IN-21, cell-permeable, negative control

STAT3-IN-21, cell-permeable, negative control, a peptide, is a negative control for Stat3 activity detection.

STAT3-IN-24, cell-permeable

STAT3-IN-24, cell-permeable (PpYLKTK-mts) is a STAT3 peptide inhibitor.

5-FAM-GpYLPQTV-NH2

5-FAM-GpYLPQTV-NH2 is a fluorescently labeled peptide and has STAT3 inhibitory activity.

Ac-GpYLPQTV-NH2

Ac-GpYLPQTV-NH2 is a STAT3 inhibitor with an IC50 value of 0.33 μM.

XZH-5

XZH-5 inhibits the phosphorylation of STAT3 and results in the induction of apoptosis and reduction of colony forming ability.

  Catalog
Abmole Inhibitor Catalog




Keywords: AC-4-130  supplier, STAT, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.